Dr Colleen Slazak, DNP, CRNA | |
100 Bowman Dr, Voorhees, NJ 08043-9612 | |
(856) 988-6260 | |
Not Available |
Full Name | Dr Colleen Slazak |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 4 Years |
Location | 100 Bowman Dr, Voorhees, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538738281 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 132077 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Researchers in this PLoS Medicine article examine the efforts necessary to reach the WHO goal of reducing mother-to-child HIV transmission (MTCT) risk to less than five percent in Zimbabwe.
Marijuana-or more specifically its active ingredient, tetrahydrocannabinol-has a well-documented tendency to stimulate hunger. And while scientists have traced this property to cannabinoid receptors in the brain, they have had little understanding of the neural circuitry underlying this effect.
New research could ease the minds of expectant mothers who may be nervous about epidurals or spinal anesthesia for childbirth. A study of New York state hospitals, published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, found the rate of anesthesia-related complications in women who received epidural or spinal anesthesia for cesarean delivery decreased 25 percent over the past decade.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 8 days ago
Entity Name | West Jersey Anesthesia Associate Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609861947 PECOS PAC ID: 6507859386 Enrollment ID: O20040407000191 |
News Archive
Researchers in this PLoS Medicine article examine the efforts necessary to reach the WHO goal of reducing mother-to-child HIV transmission (MTCT) risk to less than five percent in Zimbabwe.
Marijuana-or more specifically its active ingredient, tetrahydrocannabinol-has a well-documented tendency to stimulate hunger. And while scientists have traced this property to cannabinoid receptors in the brain, they have had little understanding of the neural circuitry underlying this effect.
New research could ease the minds of expectant mothers who may be nervous about epidurals or spinal anesthesia for childbirth. A study of New York state hospitals, published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, found the rate of anesthesia-related complications in women who received epidural or spinal anesthesia for cesarean delivery decreased 25 percent over the past decade.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 8 days ago
Entity Name | Virtua Medical Group, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Researchers in this PLoS Medicine article examine the efforts necessary to reach the WHO goal of reducing mother-to-child HIV transmission (MTCT) risk to less than five percent in Zimbabwe.
Marijuana-or more specifically its active ingredient, tetrahydrocannabinol-has a well-documented tendency to stimulate hunger. And while scientists have traced this property to cannabinoid receptors in the brain, they have had little understanding of the neural circuitry underlying this effect.
New research could ease the minds of expectant mothers who may be nervous about epidurals or spinal anesthesia for childbirth. A study of New York state hospitals, published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, found the rate of anesthesia-related complications in women who received epidural or spinal anesthesia for cesarean delivery decreased 25 percent over the past decade.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Colleen Slazak, DNP, CRNA 824 Dawn Ct, Williamstown, NJ 08094-5716 Ph: (856) 332-8224 | Dr Colleen Slazak, DNP, CRNA 100 Bowman Dr, Voorhees, NJ 08043-9612 Ph: (856) 988-6260 |
News Archive
Researchers in this PLoS Medicine article examine the efforts necessary to reach the WHO goal of reducing mother-to-child HIV transmission (MTCT) risk to less than five percent in Zimbabwe.
Marijuana-or more specifically its active ingredient, tetrahydrocannabinol-has a well-documented tendency to stimulate hunger. And while scientists have traced this property to cannabinoid receptors in the brain, they have had little understanding of the neural circuitry underlying this effect.
New research could ease the minds of expectant mothers who may be nervous about epidurals or spinal anesthesia for childbirth. A study of New York state hospitals, published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, found the rate of anesthesia-related complications in women who received epidural or spinal anesthesia for cesarean delivery decreased 25 percent over the past decade.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Researchers from the Banner Alzheimer's Institute (BAI) today announced a partnership with Novartis in a pioneering medical trial to determine whether two investigational anti-amyloid drugs-an active immunotherapy and an oral medication-can prevent or delay the emergence of symptoms of Alzheimer's in people at particularly high risk for developing the disease at older ages.
› Verified 8 days ago
Laura Faust, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Bowman Dr Fl 2, Voorhees, NJ 08043 Phone: 856-988-6260 | |
Grigoriy Levin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2301 Evesham Rd., Voorhees, NJ 08043 Phone: 856-358-4520 Fax: 856-358-8053 | |
Mrs. Shannon Mary Berks, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 502 Centennial Blvd Ste 1, Voorhees, NJ 08043 Phone: 856-874-0790 | |
Mary Gibson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2301 E Evesham Rd, Voorhees, NJ 08043 Phone: 856-358-4520 Fax: 856-358-8053 | |
Miss Rachel Ferrer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Bowman Dr Fl 2, Voorhees, NJ 08043 Phone: 856-988-6260 | |
Michael Saveriano, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4 Fawnwood Dr, Voorhees, NJ 08043 Phone: 609-841-3049 | |
Amanda Rota, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 100 Bowman Dr Fl 2, Voorhees, NJ 08043 Phone: 856-988-6260 |